Cargando…
The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism
A 43-year-old African American with end-stage renal disease (ESRD) associated with membranous nephropathy and a previously failed renal transplant had received cinacalcet to treat his secondary hyperparathyroidism. Serum calcium and phosphorus levels remained within normal limits, and serum parathyr...
Autores principales: | Khalpey, Zain, Nehs, Matthew A., ElBardissi, Andrew W., Semel, Marcus, Tullius, Stefan G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421548/ https://www.ncbi.nlm.nih.gov/pubmed/25949409 http://dx.doi.org/10.1093/ndtplus/sfp120 |
Ejemplares similares
-
Calciphylaxis
por: Mulrow, Patrick J.
Publicado: (1962) -
Calciphylaxis
por: Neild, G. H., et al.
Publicado: (2013) -
Calciphylaxis
por: Harb, Jennifer, et al.
Publicado: (2015) -
Gastrointestinal Bleeding Secondary to Calciphylaxis
por: Gupta, Nancy, et al.
Publicado: (2015) -
Literature review in the treatment of calciphylaxis: A case with uncontrolled and severe secondary hyperparathyroidism
por: Ozdemir, Ali Abbas, et al.
Publicado: (2016)